and apoptosis have been reported as a type of cell death of DND, but its molecular mechanisms remain largely unclear. 6, 7 The role of calcium (Ca 2ϩ ) in ischemic neuronal death is well recognized. 8 An excessive postischemic Ca 2ϩ mobilization occurs in CA1 neurons 9, 10 by both glutamateinduced Ca 2ϩ influx 11, 12 and/or inositol 1,4,5-trisphosphate (IP 3 )-induced Ca 2ϩ release from intracellular stores. 13, 14 Elevated intracellular Ca 2ϩ concentration in turn activates a series of enzymes including proteases, phospholipases, phosphatases and protein kinases. It may also trigger the synthesis of the free radical nitric oxide (NO), involved in neuronal apoptosis. 15 Among the Ca 2ϩ -activated enzymes, the authors will focus on the cysteine proteases calpain (EC 3.4.22.17) and cathepsins (particularly cathepsins B (EC 3.4.22.1) and L (EC 3.4.22.15)), because of the recent progress in understanding their role in the pathogenesis of DND. [16] [17] [18] Calpain is a cytosolic cysteine protease ubiquitously and constitutively expressed in mammalian cells. 19 Two forms of the enzyme are known: µ-calpain (calpain I) and m-calpain (calpain II). They differ in their sensitivity to Ca 2ϩ , µ-calpain being activated at a low (micromolar) Ca 2ϩ concentration, while m-calpain is activated at a higher (millimolar) Ca 2ϩ concentration. Calpains are considered to participate in various intracellular signaling pathways mediated by Ca 2ϩ . They are heterodimers, consisting of 30 and 80 kDa subunits. The small subunits are identical among one and the same tissue and/or animal species, while the large subunits are similar but not identical. A very specific endogenous inhibitor, calpastatin, which interacts with the Ca 2ϩ -binding domains of both large and small subunits, inhibits calpain. The coexistence of calpain and calpastatin in cells suggests a pivotal role of this inhibitor in the regulation of calpain activity. 20 Like calpains, cathepsins also belong to the papain superfamily of cysteine proteases. 21 They are synthesized as inactive precursors and require proteolytic activation that Neuropathology 1999; 19, 356-365 A few days after a transient brain ischemia, the pyramidal neurons in the cornu Ammonis (CA) 1 sector of the hippocampus undergo selective death, a process named delayed neuronal death (DND). Cell death may occur as necrosis and/or apoptosis, and both have been reported to take place in DND. The cell's decision between apoptosis and necrosis may depend on the strength of the insult, the balance of downstream signal transduction systems, and the expression level of pro-and anti-apoptotic or necrotic factors. Cytosolic calcium (Ca 2؉ ) overload specifically occurs in the CA1 neurons after ischemia and thus is considered a common triggering event of the death cascade. As Ca 2؉ activates a wide array of intracellular enzymes, many Ca 2؉ -targeted enzymes have been implicated in DND. Among these, the present review will focus on the cysteine proteases calpain and cathepsins (B and L). In addition, their possible interactions with another family of cysteine proteases, caspases, will be discussed in relation to the cellular fate toward apoptosis or necrosis.
INTRODUCTION
Cerebral ischemia has profound effects on the brain, inducing both immediate and delayed injuries. Even a transient ischemic insult is sufficient to cause selective damage to certain sensitive brain regions. The cornu Ammonis (CA) 1 sector of the hippocampus is considered such a region, since a transient global ischemia is able to cause neuronal death a few days after cerebral ischemia. This phenomenon is designated as delayed neuronal death [29] [30] [31] [32] [33] (Table 1 ). In relation to the latter, selective nuclear transport of µ-calpain has been demonstrated. 38 It is worth noting that calpastatin itself is also a target of calpain, 35 and µ-calpain is capable of activating mcalpain. 37 Thus, a calpain cascade may coordinate the functions of calpains in cells. A variety of calpain functions have been proposed including intracellular protein degradation, platelet aggregation, erythrocyte aging, neutrophil activation as well as long-term potentiation in the hippocampus. Detailed data on the physiological functions of calpains are available in other reviews. [19] [20] [21] Cathepsins were shown to participate in the extracellular matrix remodeling, and cathepsin K is considered the most potent elastolytic enzyme known. 21 44 Cathepsins are essential for the generation of antigenic peptides in the major histocompatibility complex class II antigen presentation (cathepsin S) 21 as well as for the processing of prohormone molecules, such as pro-endothelin-1 (cathepsin D) 45 and prorenin (cathepsin B). 46 Cathepsin B is also capable of cleaving the myristoylated alanine-rich C kinase substrate (MARCKS), 47 a major cellular substrate of protein kinase C.
Cathepsin L has been implicated in tumor progression and bone resorption. 21, 22 Interestingly, members of the caspase (the other major cysteine protease) superfamily, NF-68, neurofilament 68 kDa protein; PKC, protein kinase C; EGF, epidermal growth factor; PDGF, platelet-derived growth factor; AP-1, activator protein-1; CREB, cyclic AMP response element-binding protein; eIF-4E, eukaryotic initiation factor-4E; c-Myc, c-myelocytoma oncogene product. namely caspase-11 and to a lesser extent caspase-1, have recently been shown to be substrates of cathepsin B, 48 while caspase-3 has been shown to be a substrate of cathepsin L. 49 These data, together with the observation of caspasemediated calpastatin degradation, 50 suggest a potential interaction between the caspase and papain superfamilies in integrating their cellular effects.
CALPAIN AND CATHEPSIN INVOLVEMENT IN ISCHEMIC DELAYED NEURONAL DEATH
Analyzing postischemic neuronal Ca 2ϩ mobilization by an in vitro ischemia experiment using acute hippocampal slices, Yamashima et al. measured intracellular free Ca 2ϩ ([Ca 2ϩ ] i ) during hypoxia-hypoglycemia. 16 The area of the maximum [Ca 2ϩ ] i elevation in the slice (Fig. 1 ) was selectively localized to the CA1 sector, the area of DND in vivo. In previous studies, indirect evidence of Ca 2ϩ -induced calpain involvement in DND has been demonstrated by the finding of calpain-mediated fodrin degradation, associated with Ca 2ϩ -induced calpain activation in CA1 neurons after brain ischemia. 24 Using an antibody that specifically reacts with an activated form of µ-calpain 51 and a primate model of 20-min whole-brain complete ischemia, Yamashima et al. provided direct evidence of calpain activation prior to DND. 16 At immunohistochemistry, the perikarya of CA1 neurons, immediately after the ischemic insult, showed a specific staining of activated µ-calpain (Fig. 2a,b) as compared with both the controls and the remaining ischemia-resistant hippocampal neurons (data not shown). This observation was confirmed by western blot analysis of the respective hippocampal sectors (Fig. 2c) . Most importantly, the [Ca 2ϩ ] i levels increased only transiently during hypoxia-hypoglycemia in vitro (Fig. 1) , while calpain activation in vivo persisted long after [Ca 2ϩ ] i had returned to the normal level. Immunoelectron microscopy of the hippocampal slices using anti-activated µ-calpain antibody revealed that activated µ-calpain was localized at the vacuolated or disrupted membrane of lysosomes (Fig. 2d) . Taken together, these data suggest that excessive calpain activation in postischemic CA1 17, 18 Immediately after ischemia, the cathepsin B immunoreactivity of CA1 neurons was significantly increased, and was localized not only to the lysosomes but also to the perikarya or the neuropil (Fig. 3a,b) . In contrast, the cathepsin B immunoreactivity in the ischemia-resistant hippocampal neurons also increased after ischemia but did not show extralysosomal distribution (Fig. 3c,d ). Such a difference in the immunolocalization of cathepsin B was also evident at the ultrastructural level.When the cathepsin B-selective inhibitor CA-074 was applied to the monkeys immediately after the ischemic insult, the immunoreactivity of cathepsin B in the lysosomal granules of CA1 neurons became much weaker, and no extralysosomal immunoreactivity was observed (Fig. 3e) .
Quantification of cathepsin B enzyme activity in each hippocampal sector displayed a similar pattern showing an increase in all sectors 3-5 days after the ischemic insult, the application of CA-074 diminishing this effect (Fig. 4a) . 18 Cathepsin L activity showed a similar pattern (Fig. 4b) .
Therefore, Ca 2ϩ -induced calpain overactivation after transient brain ischemia may lead to disruption of lysosomes with the resultant release of cathepsins. The latter may gradually degrade cell constituents, thus contributing to the development of DND (calpain-cathepsin hypothesis). [16] [17] [18] The extralysosomal release of cathepsin enzymes occurring specifically in the CA1 sector may explain the restricted localization of DND to this hippocampal region.
POTENTIAL INTERACTIONS OF CALPAIN, CATHEPSIN AND CASPASES IN DELAYED NEURONAL DEATH
Recently, apoptosis (programmed cell death) has been proposed as a mechanism of neuronal damage in DND, particularly in rodents. 6, 7 Dying ischemic neurons in different brain regions, including CA1, showed morphological features of apoptosis and a positive labeling of nuclear double-strand DNA breaks in situ (terminal deoxynucleotidl transferase dUTP nick end labeling (TUNEL) assay) together with DNA fragmentation. 55, 56 Since another superfamily of cysteine proteases, the aspartyl-specific cysteine proteases (caspases), 57 is well known to have an important role in neuronal apoptosis during development and also in various pathological conditions, 58 their involvement in ischemic DND is currently a major subject of investigation. Based on their regulation and sequence of activation, caspases are classified as initiator (e.g. caspase-8, -9, -10) and effector (e.g. caspase-3, -6, -7) classes. 57 In rodents, caspase-3 activation in transient global ischemia has been reported as The residual cathepsin activity in the CA1 sector at postischemic day 5 after CA-074 (a selective cathepsin B inhibitor) treatment was 36% for cathepsin B (a) and 80% for cathepsin L (b), compared with the respective untreated day 5 groups. However, after E-64c (a non-selective inhibitor) treatment, the residual cathepsin activity in the CA1 sector was 14% for cathepsin B (a) and 43% for cathepsin L (b), compared with the respective untreated day 5 groups. 5d, untreated day 5 group; 5d(CA-074), CA-074-treated group; 5d(E-64c), E-64c-treated group. (a) *P < 0.01 versus control; **P Ͻ 0.05 versus control and day 5; ***P Ͻ 0.01 versus day 5. (b) *P Ͻ 0.05 versus control; **not significant; ***P Ͻ 0.01 versus day 5.
showing a selective and prolonged caspase-3 mRNA and protein induction in the CA1 neurons prior to apoptosis. [59] [60] [61] Furthermore, a specific inhibitor of caspase-3 significantly reduced CA1 neuronal death. 59, 61 Therefore, up-regulation of caspase-3 in dying CA1 neurons may be an important step in the development of the postischemic DND of rodents.
As mentioned, caspase-3 and calpain have common substrates in neurons, including α-spectrin 25 and neurofilament proteins. 26 A temporal relationship between calpain/caspase-3 activation and α-spectrin degradation prior to DNA fragmentation and apoptosis was established. 62 Calpain activation in apoptosis upstream of caspases, 63 and caspase-3-mediated calpastatin degradation 35 inducing calpain activation in non-neuronal cells, were shown. Furthermore, cathepsin B activates caspase-11 upstream of caspase-3-mediated liver cell apoptosis, 48 and cathepsin L activates caspase-3-like protease, also in liver cells. 49 These data suggest that a mutual communication may exist between members of the two large cysteine protease superfamilies in executing their roles in DND (Fig. 5) . Thus, a calpain-cathepsin-caspase cascade might be involved in the primate postischemic CA1 DND.
The role of mitochondria in necrosis has been recognized for decades, while their implication in apoptosis has recently also become clear. 64 The induction of mitochondrial permeability transition (MPT), a process of disruption of mitochondrial membrane integrity, is considered a key step in the execution of apoptosis. 65 Mitochondrial permeability transition is thought to be caused by factors such as mitochondrial calcium overload and results in release of cytochrome c and caspase-9 from the intermembrane space of mitochondria, which triggers the caspase cascade prior to apoptosis. 64 In postischemic hippocampal slices, cytochrome c was released into the cytosol 66 and the activation of MPT among various brain regions correlated with their susceptibility to ischemic damage. 67 In addition, the MPT inhibitor cyclosporin A ameliorated hippocampal CA1 neuronal damage after transient global ischemia in rodents. 68 Thus, it is tempting to speculate that in the primate postischemic DND, both calpain-cathepsin-and MPT-triggered caspase activation might induce neuronal degeneration and death (Fig. 5) .
THERAPEUTIC STRATEGIES AND FUTURE PESPECTIVES
Assuming that cysteine proteases are involved in the development of ischemic brain injury, it is reasonable to predict that their inhibition, even if applied after the ischemic insult, could have a protective effect on the degenerating postischemic neurons. 69 In particular, calpain 70 and caspase 71 inhibition has successfully blocked ischemic CA1 DND in rodents. As described, selective cathepsin B ] i may lead to calpain-cathepsin-mediated activation of caspase-11 (cathepsin B) or caspase-3 (cathepsin L) and, on the other hand, to mitochondrial calcium overload resulting in release of proteins such as cytochrome c and caspase-9 through the mitochondrial permeability transition (PT) pore. Both pathways converge on caspase-3-induced DNase activation leading to apoptosis. Concurrently, degradation of still unknown cellular constituents by extralysosomal cathepsins B and L in addition to mitochondrial factors may lead to necrosis. In addition to its interaction with cathepsins and caspases, calpain may also mediate cleavage of cytoplasmic (such as cytoskeleton) and nuclear (such as c-Fos/ c-Jun, p53, cyclin D1) proteins. Caspases (via calpastatin) may provide a positive feedback link to calpain, perpetuating its activity. PL, plasmalemma; NL, nucleolemma; IM, inner mitochondrial membrane; OM, outer mitochondrial membrane.
inhibition was able to prevent ischemic DND in monkeys. 17 Also, the non-selective cysteine protease inhibitor E-64c that inhibits not only cathepsins B, H and L, but also calpain had a greater potency in reversing DND compared with the selective cathepsin B blocker (Fig. 4b) . 18 This is further evidence implicating calpain and cathepsin enzymes in the development of DND.
In addition to inhibitors of cysteine proteases and cyclosporin A, several drugs, such as the gamma-aminobutyric acid (GABA) agonist diazepam, 72 the microtubuledisrupting agent colchicine 73 and the immunosuppressant FK-506, 74 displayed a neuroprotective effect on CA1 neurons after transient global ischemia. A similar effect was confirmed also for acidic fibroblast growth factor, 75 hepatocyte growth factor, 76 and interleukin-3. 77 The effect of diazepam is probably mediated via the mitochondrial benzodiazepine receptor, 64 in a similar way to cyclosporin A. Both cyclosporin A and FK-506 inhibit the cytoplasmic protein phosphatase calcineurin; however, FK-506 lacks the ability of inhibiting MPT. Therefore, calcineurin, a calpain substrate, 20 may be involved in postischemic DND in a MPT-independent fashion.
It is now recognized that cell death may take place by necrosis or apoptosis. The prevalence of either type of death in various neuropathologies including ischemia is debatable at present. 78, 79 In particular, both necrotic and apoptotic features have been reported in CA1 DND. In various models of total brain ischemia, including the primate model described above, [16] [17] [18] the features of CA1 neuronal death were essentially necrotic. However, evidence of apoptosis has also been reported in gerbils. 6 In the context of the involvement of calpain-cathepsin cascade in CA1 neuronal necrosis and of mitochondrial factors-caspase cascade in apoptosis, we would like to propose two possible models of the occurrence and prevalence of necrosis and apoptosis in CA1 DND (Fig. 6) . In both models an interaction between the two systems, calpain-cathepsin and mitochondrial factors-caspase, takes place prior to cell death. In one model, the two systems may separately lead to necrosis or apoptosis depending on the severity of the insult (Fig. 6a) , and the cell fate is determined by the relative prevalence of their components. In the other model, a common calpaincathepsin-caspase cascade (with the participation of mitochondrial factors) may execute cell death (Fig. 6b) . That is, a cathepsin-mediated apoptosis 48, 49 and a caspasemediated necrosis [80] [81] [82] may simultaneously take place, and it is the severity of insult that determines whether cell death will be restricted to apoptosis only or whether necrosis will eventually follow. Future studies on the temporal and quantitative pattern of the gene expression of various proand anti-apoptotic and necrotic factors will shed more light on their precise role in DND as well as the contribution of apoptosis and necrosis to the development type of neuronal damage.
Fig. 6
Two hypothetical models of relation of necrosis and apoptosis to delayed neuronal death (DND). (a) Separate death cascades execute necrosis and apoptosis: severe insults activate calpain-cathepsin cascade leading to necrosis, while milder insults activate mitochondrial factors-caspase cascade leading to apoptosis. The two systems may interact and thus regulate their activity. (b) A common calpain-cathepsincaspase cascade (with the involvement of mitochondrial factors) executes cell death. In this case, apoptosis is considered a step prior to development of necrosis.
